Biomx Inc Financials
This page shows Biomx Inc (PHGE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
BiomX remains a research-led cash burner, but FY2025 shows the financing cushion has largely run out.
Operating cash burn stayed close to-$21.3M in FY2023 and-$26.4M in FY2025, so the core spending pace did not really reset. What changed was funding capacity: cash fell to$4.4M and equity to-$1.3M in FY2025, so similar burn is now landing on a balance sheet that no longer carries its own buffer.
Cash conversion is unusually direct in a negative sense: FY2025 operating cash flow of
The cost base is still centered on research, with R&D at
Financial Health Signals
Biomx Inc does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Biomx Inc recorded an outflow of $26.4M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents an increase of 28.7% from the prior year.
Biomx Inc held $4.4M in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Margins & Returns
None of these metrics is reported for fiscal year 2025.
Capital Allocation
Biomx Inc invested $21.3M in research and development in fiscal year 2025. This represents a decrease of 13.7% from the prior year.
Biomx Inc invested $2K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 93.3% from the prior year.
Not reported for fiscal year 2025.
PHGE Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $332K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | $235K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $97K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | $6.1M+22.1% | $5.0M-4.5% | $5.3M | N/A | $7.3M |
| SG&A Expenses | $5.4M+234.1% | $1.6M | N/A | $2.4M-0.2% | $2.4M-3.5% | $2.5M | N/A | $3.2M |
| Operating Income | -$5.4M-317.7% | -$1.3M | N/A | -$8.5M-14.8% | -$7.4M+4.2% | -$7.8M | N/A | -$11.3M |
| Interest Expense | $20K-89.6% | $192K | N/A | $5K0.0% | $5K-99.4% | $850K | N/A | $5K |
| Income Tax | N/A | N/A | N/A | $3K+50.0% | $2K+100.0% | $1K | N/A | N/A |
| Net Income | -$3.8M | N/A | N/A | -$9.2M-51.8% | -$6.0M+21.2% | -$7.7M | N/A | $9.6M |
| EPS (Diluted) | $0.37 | $7.38 | $21.39 | $0.29-92.1% | $3.66-41.6% | $6.27-88.8% | $55.86+18119.4% | -$0.31 |
PHGE Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $28.2M+767.0% | $3.3M-43.8% | $5.8M-77.9% | $26.2M-31.2% | $38.0M-16.7% | $45.7M+5.6% | $43.2M-27.9% | $60.0M |
| Current Assets | $2.4M-20.6% | $3.0M-45.4% | $5.6M-37.1% | $8.9M-46.7% | $16.6M-29.3% | $23.5M+14.7% | $20.5M-27.5% | $28.3M |
| Cash & Equivalents | $347K-70.3% | $1.2M-73.2% | $4.4M-37.0% | $6.9M-50.7% | $14.0M-30.2% | $20.1M+19.3% | $16.9M-28.4% | $23.5M |
| Accounts Receivable | $327K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | $801K0.0% | $801K |
| Total Liabilities | $17.3M+319.2% | $4.1M-41.7% | $7.1M-54.8% | $15.7M-17.0% | $18.9M-10.7% | $21.2M+10.8% | $19.1M-13.6% | $22.1M |
| Current Liabilities | $10.2M+316.0% | $2.4M-61.6% | $6.4M+22.1% | $5.2M-16.5% | $6.3M-10.8% | $7.0M-15.1% | $8.3M-7.6% | $8.9M |
| Long-Term Debt | $247K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $10.9M+1333.3% | -$881K+32.3% | -$1.3M-112.4% | $10.5M-45.3% | $19.2M-21.8% | $24.5M+1.5% | $24.1M-36.3% | $37.9M |
| Retained Earnings | -$239.8M-1.6% | -$236.0M-8.8% | -$216.9M-6.6% | -$203.6M-4.7% | -$194.4M-3.2% | -$188.4M-4.2% | -$180.7M-8.7% | -$166.2M |
Not reported in any period shown, so not listed: Inventory.
PHGE Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.2M+78.4% | -$5.4M-23.4% | -$4.4M+38.9% | -$7.2M-17.6% | -$6.1M+29.9% | -$8.7M-38.5% | -$6.3M+22.3% | -$8.1M |
| Capital Expenditures | N/A | N/A | $0 | N/A | N/A | N/A | $11K+10.0% | $10K |
| Free Cash Flow | N/A | N/A | -$4.4M | N/A | N/A | N/A | -$6.3M+22.3% | -$8.1M |
| Investing Cash Flow | -$556K+44.2% | -$996K-99700.0% | $1K+150.0% | -$2K-103.4% | $58K+13.7% | $51K+5200.0% | -$1K0.0% | -$1K |
| Financing Cash Flow | $905K-65.5% | $2.6M+109.7% | $1.3M+2216.7% | $54K+286.2% | -$29K-100.2% | $11.9M+3093.2% | -$398K | $0 |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
PHGE Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 29.2% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | -1630.7% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | -1158.4% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | -35.4% | N/A | N/A | -87.4%-55.9pp | -31.5%-0.3pp | -31.3% | N/A | 25.4% |
| Return on Assets | -13.7% | N/A | N/A | -35.0%-19.2pp | -15.9%+0.9pp | -16.8% | N/A | 16.1% |
| Current Ratio | 0.24-1.0x | 1.24+0.4x | 0.87-0.8x | 1.70-1.0x | 2.66-0.7x | 3.35+0.9x | 2.48-0.7x | 3.17 |
| Debt-to-Equity | 0.02 | N/A | N/A | 1.50+0.5x | 0.99+0.1x | 0.86+0.1x | 0.79+0.2x | 0.58 |
Not reported in any period shown, so not listed: FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Note: Shareholder equity is negative (-$1.3M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.87), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Where Biomx Inc Ranks
Frequently Asked Questions
What is Biomx Inc's free cash flow?
Biomx Inc (PHGE) recorded an outflow of $26.4M in free cash flow during fiscal year 2025. This represents a 28.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Biomx Inc's operating cash flow?
Biomx Inc (PHGE) recorded an outflow of $26.4M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Biomx Inc's total assets?
Biomx Inc (PHGE) had $5.8M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Biomx Inc's capital expenditures?
Biomx Inc (PHGE) invested $2K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Biomx Inc spend on research and development?
Biomx Inc (PHGE) invested $21.3M in research and development during fiscal year 2025.
What is Biomx Inc's current ratio?
Biomx Inc (PHGE) had a current ratio of 0.87 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
How does Biomx Inc's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Biomx Inc (PHGE) held $4.4M in cash, cash equivalents and investments, and reported an operating cash outflow of $26.4M over that year. Dividing the one by the other, the reported balance equals about 2 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Why is Biomx Inc's debt-to-equity ratio negative or not reported?
Biomx Inc (PHGE) has negative shareholder equity of -$1.3M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.